Retatrutide for Bodybuilding Cutting: Complete Cycle Guide

Why Bodybuilders Use Retatrutide for Cutting

Retatrutide’s triple-agonist mechanism makes it particularly suited for bodybuilding cutting phases. The GLP-1 component suppresses appetite, making caloric restriction significantly easier. The glucagon component increases energy expenditure through lipolysis — the breakdown of stored fat for fuel. This means retatrutide users burn more calories at rest, which accelerates fat loss during a caloric deficit. The combination of reduced appetite and increased energy expenditure creates a metabolic environment that is difficult to achieve through diet and exercise alone.

Dosing for a Cutting Phase

Bodybuilders typically use lower retatrutide doses during a cutting phase than the 12 mg clinical trial maximum. Doses of 4-8 mg weekly are common, as they provide significant appetite suppression and metabolic effects while minimizing the risk of excessive muscle loss and training fatigue. The Phase 2 data supports this approach: 4 mg produces 15-17% weight loss and 8 mg produces 20-22%, both of which are sufficient for a productive cutting phase. Starting at 2 mg and titrating up every 4 weeks allows the body to adapt while preserving training performance.